Sudarshan Pharma Industries Ltd

BSE: 543828

total announcements

543828.BO · 15 min delayed

BSEInsider Trading / SASTPledge10 Aug 2026

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 08, 2026 for Hemal Vasantrai Mehta

Sudarshan Pharma Industries Ltd has made a disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the un-pledge of shares held by Mr. Hemal Mehta, a promoter of the company.

Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone ....

Sudarshan Pharma Industries Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve Unaudited Standalone Financial Results for the quarter ended 30/06/2026.